Iambic Therapeutics

top of page

Jun 24, 2024

Iambic Therapeutics' Co-Founder and CEO on this month's $50M Series B Extension and the company's AI driven pipeline

Tom Miller describes the rationale for the raise and what it will allow Iambic to do, how he believes the company's AI approach is unique

Follow BiotechTV

Also look for unique social pages for BiotechTV U.

Sponsor Spotlight

At Savills, the Life Sciences Team specializes in helping biotech companies unlock their full potential by aligning real estate strategies with their scientific and business goals. As a leading global commercial real estate advisory firm, we focus exclusively on occupier services and tenant representation, acting as a trusted partner to some of the most innovative companies in the industry.

Visit Saville's Life Sciences Overview

bottom of page

Iambic Therapeutics' Co-Founder and CEO on this month's $50M Series B Extension and the company's AI driven pipeline

Follow BiotechTV

Sponsors

Sponsor Spotlight